|
|
|
|
| LEADER |
01675nam a2200337 u 4500 |
| 001 |
EB001865467 |
| 003 |
EBX01000000000000001029547 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190504 r ||| eng |
| 100 |
1 |
|
|a Mayhew, Alain
|
| 245 |
0 |
0 |
|a Intravenous lidocaine for chronic pain
|h Elektronische Ressource
|b a review of the clinical effectiveness and guidelines
|c author, Alain Mayhew, Charlene Argáezez
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c 2018, January 26, 2018
|
| 300 |
|
|
|a 1 PDF file (22 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographic references
|
| 653 |
|
|
|a Lidocaine / therapeutic use
|
| 653 |
|
|
|a Chronic Pain / drug therapy
|
| 653 |
|
|
|a Administration, Intravenous
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Lidocaine / administration & dosage
|
| 653 |
|
|
|a Guidelines as Topic
|
| 700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK531808
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this Rapid Response is to collect, critically appraise and evaluate the current evidence on the clinical effectiveness and adverse effects of intravenous lidocaine in treating chronic pain, as well as to review recent evidence-based guidelines for its use in patients with chronic pain
|